Schou Morten, Torp-Pedersen Christian, Gustafsson Finn, Abdulla Jawdat, Kober Lars
Department of Cardiology, The Heart Centre, Rigshospitalet University Hospital, DK-2100 Copenhagen O, Denmark.
Eur J Heart Fail. 2008 Jul;10(7):682-8. doi: 10.1016/j.ejheart.2008.04.006. Epub 2008 Jun 18.
This study was designed to assess whether the prognostic significance of estimated glomerular filtration rate (eGFR) and left ventricular ejection fraction (LVEF) interact in populations with heart failure (HF) and myocardial infarction (MI).
Patients were recruited from four screening registers (N=18,010) including patients admitted with HF or MI. Ten years follow-up was recorded and formal testing for interactions between eGFR and LVEF with respect to outcome was done.
Twelve-thousand-and-ninety patients died. A significant interaction (P=0.010) was found and each parameter became relatively more important when the value of the other was low. eGFR and LVEF were reparameterized to categorical variables and we observed that chronic kidney disease stage II was associated with a decreased (Hazard ratio (HR): 0.79 (95% Confidence Interval: 0.72-0.86)) and chronic kidney disease stages IV (HR: 1.60 (1.45-1.91) and V (HR: 1.91 (1.45-2.52) were associated with an increased mortality risk with an additive effect of left ventricular systolic dysfunction (LVSD).
The prognostic significance of eGFR and LVEF is synergistic in patients with HF or MI and the impact of one parameter is inversely related to the level of the other. Statistical interactions are scale dependent and the relationship between chronic kidney disease stages I to V and mortality risk is J-shaped with an additive effect of LVSD.
本研究旨在评估在心力衰竭(HF)和心肌梗死(MI)人群中,估计肾小球滤过率(eGFR)和左心室射血分数(LVEF)的预后意义是否相互作用。
从四个筛查登记处招募患者(N = 18,010),包括因HF或MI入院的患者。记录了十年的随访情况,并对eGFR和LVEF之间关于结局的相互作用进行了正式测试。
12,090名患者死亡。发现了显著的相互作用(P = 0.010),并且当另一个参数的值较低时,每个参数变得相对更重要。eGFR和LVEF被重新参数化为分类变量,我们观察到慢性肾脏病II期与死亡率降低相关(风险比(HR):0.79(95%置信区间:0.72 - 0.86)),而慢性肾脏病IV期(HR:1.60(1.45 - 1.91))和V期(HR:1.91(1.45 - 2.52))与死亡风险增加相关,且存在左心室收缩功能障碍(LVSD)的累加效应。
在HF或MI患者中,eGFR和LVEF的预后意义具有协同作用,一个参数的影响与另一个参数的水平呈负相关。统计相互作用依赖于尺度,慢性肾脏病I至V期与死亡风险之间的关系呈J形,且存在LVSD的累加效应。